1. FDA’s Policy Statement for the Development of New Stereo Isomeric Drugs, 417 US Food and Drug Administration. Federal Regulations 22, 1992, pp. 249.c
2. FDA, Guidance for Industry: PAT—A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance, 2004, September.
3. Simulated moving bed chromatography for the separation of enantiomers;Rajendran;J. Chromatogr. A,2009
4. Determination of ibuprofen and naproxen in tablets;Sadecká;J. Pharm. Biomed. Anal.,2001
5. Study on the enzymatic hydrolysis of racemic methyl ibuprofen ester;Madhav;J. Chem. Technol. Biotechnol.,2001